Trademark search for:

VIMBREXA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2020-10-22 — Application filed
2020-10-26 — Application filed
2020-12-10 — Application filed
2021-03-23 — Assigned to examiner
2021-03-24 — Approved for pub - principal register
2021-04-07 — Notification of notice of publication e-mailed
2021-04-27 — Published for opposition
2021-04-27 — Official gazette publication confirmation e-mailed
2021-06-22 — Noa e-mailed - sou required from applicant
2021-10-22 — Sou teas extension received
2021-10-22 — Sou extension 1 filed
2021-10-22 — Sou extension 1 granted
2021-10-26 — Notice of approval of extension request e-mailed
2022-04-20 — Sou teas extension received
2022-04-20 — Sou extension 2 filed
2022-04-20 — Sou extension 2 granted
2022-04-22 — Notice of approval of extension request e-mailed
2022-10-17 — Assigned to examiner
2023-01-23 — Application abandoned
2023-01-23 — Application abandoned
2023-01-23 — Final status recorded

Owner Information

Primus Pharmaceuticals, Inc.
Scottsdale , AZ

Correspondent

Marie Lavalleye COVINGTON & BURLING LLP
ONE CITYCENTER, 850 TENTH STREET NW
WASHINGTON, DC 20001
UNITED STATES

Filing Details

Filing Date:
2020-10-22

Status Date:
2023-01-23

Category:
Pharmaceuticals

Filing Year:
2020

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.